Eisai Co Ltd
TSE:4523
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4 618
7 710
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Eisai Co Ltd
Revenue
Eisai Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Eisai Co Ltd
TSE:4523
|
Revenue
ÂĄ733.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
||
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Revenue
ÂĄ4.5T
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
||
Daiichi Sankyo Co Ltd
TSE:4568
|
Revenue
ÂĄ1.8T
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
||
Otsuka Holdings Co Ltd
TSE:4578
|
Revenue
ÂĄ2.3T
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
4%
|
||
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Revenue
ÂĄ1.1T
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
10%
|
||
Astellas Pharma Inc
TSE:4503
|
Revenue
ÂĄ2.1T
|
CAGR 3-Years
18%
|
CAGR 5-Years
10%
|
CAGR 10-Years
6%
|
Eisai Co Ltd
Glance View
Eisai Co., Ltd., founded in 1941 and headquartered in Tokyo, Japan, stands as a prominent global player in the pharmaceutical industry, dedicated to research and development in areas such as neurology and oncology. With a mission encapsulated in their philosophy of "human health care" (hhc), Eisai strives not only for profit but also for the well-being of patients, positioning itself as a company that deeply values purpose alongside its financial goals. Over the years, Eisai has gained recognition for its innovative products, particularly the Alzheimer's treatment, Aricept, which has generated a substantial portion of its revenue. Investors might find this focus on neurodegenerative diseases particularly compelling, given the aging global population and the increasing prevalence of conditions like Alzheimer's. Eisai's commitment to innovation is complemented by strategic partnerships and collaborations, including notable alliances with big biotech and pharmaceutical companies, enhancing its research capabilities and market reach. With a firm commitment to sustainability and environmental issues, the company not only focuses on profitability but also adheres to a long-term vision that resonates with contemporary investment ideals. As Eisai moves forward, its pipeline of products, including promising cancer therapies, offers investors a glimpse into its growth potential and the company's adaptability within a rapidly changing healthcare landscape. This combination of ethical responsibility, strategic growth, and market relevance positions Eisai as an intriguing prospect for investors searching for both stability and potential in the pharmaceutical sector.
See Also
What is Eisai Co Ltd's Revenue?
Revenue
733.8B
JPY
Based on the financial report for Jun 30, 2024, Eisai Co Ltd's Revenue amounts to 733.8B JPY.
What is Eisai Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
2%
Over the last year, the Revenue growth was -3%. The average annual Revenue growth rates for Eisai Co Ltd have been 3% over the past three years , 3% over the past five years , and 2% over the past ten years .